Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia

Previous studies have shown that metformin or statins may decrease hepatocellular carcinoma (HCC) in diabetic patients. Accordingly, this article evaluates whether combination therapy may further reduce HCC. Newly diagnosed type 2 diabetes mellitus (DM) patients, excluding those with history of mali...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Chen, Hsin-Hung, Lin, Ming-Chia, Muo, Chih-Hsin, Yeh, Su-Yin, Sung, Fung-Chang, Kao, Chia-Hung
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2016
Soggetti:
4200
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616544/
https://ncbi.nlm.nih.gov/pubmed/26091447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi